Position in PLNH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$19
New position
Shares Held
125
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 5 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Ancora Advisors LLC holds $9,377,058 across 14 Drug Manufacturers - Specialty & Generic names. PLNH ranks #13 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
49,499 | $5,851,276 | |
| 2 | EBS |
Emergent BioSolutions Inc.
|
409,267 | $3,396,915 | |
| 3 | HLN |
Haleon plc
|
4,555 | $45,595 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,819 | $33,687 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
899 | $21,513 | |
| 6 | VTRS |
Viatris Inc
|
1,313 | $17,738 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
10 | $5,929 | |
| 8 | PRGO |
PERRIGO Co plc
|
313 | $3,361 |
All Filings in PLNH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19 | 125 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||